NOVN:SWX
Novartis AG
CHFÂ 125.82
arrow_downward
-2.90%(-3.76) 1D
Sep 7, 5:18:46 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHFÂ 124.64
High
CHFÂ 127.22
Low
CHFÂ 124.60
Mkt. cap
256.66B
Avg. vol.
2.20M
Volume
2.32M
Dividend
2.94%
Quarterly dividend
CHFÂ 0.92
Ex-dividend date
Mar 10, 2026
P/E ratio
23.48
52-wk high
CHFÂ 132.68
52-wk low
CHFÂ 96.03
EPS
CHFÂ 5.36
Shares outstanding
2.03B
No. of employees
75K
Open
CHFÂ 124.64
High
CHFÂ 127.22
Low
CHFÂ 124.60
Mkt. cap
256.66B
Avg. vol.
2.20M
Volume
2.32M
Dividend
2.94%
Quarterly dividend
CHFÂ 0.92
Ex-dividend date
Mar 10, 2026
P/E ratio
23.48
52-wk high
CHFÂ 132.68
52-wk low
CHFÂ 96.03
EPS
CHFÂ 5.36
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
Zacks Investment Research
·
1 hour ago
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
Reuters
·
4 hours ago
Novartis cholesterol setback tests hopes for emerging heart disease drugs
Yahoo Finance
·
6 hours ago
European shares dip as higher oil prices weigh; Novartis slips
Investing.com
·
6 hours ago
Why is Novartis stock sliding today?
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com